Latest / Decera Clinical Education Oncology Podcast
Combining PARP inhibitors With Other Treatments for Men With Prostate Cancer: Clinical Trial Updates
In this episode, Karim Fizazi, MD, PhD, and Joaquin Mateo, MD, PhD, consider the potential implications of ongoing and planned clinical trials using PARP inhibitors in combination with other therapies to treat men with prostate cancer including:
PARP inhibitors combined with androgen receptors
Phase III trials of PARP inhibitors with androgen receptor–directed therapy
PARP inhibitors combined with immunotherapy
PARP inhibitors and DNA damaging agents
Presenters:
Karim Fizazi, MD, PhD
Full Professor
Cancer Medicine
Institut Gustave Roussey
Villejuif, France
Joaquin Mateo, MD, PhD
Attending…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.